Progression free survival by the treatment with Cabozatinib in a case of BRAF mutated Radioiodine refractory recurrent metastatic Papillary Carcinoma Thyroid. Bangladesh J of Otorhinolaryngology. 2026;31(2):86-94. doi:10.3329/bjo.v31i2.89000